3 Of 5 Remaining Claims Of Kickbacks Survive In Cancer Drug Lawsuit

Mealey's (November 16, 2020, 11:01 AM EST) -- PHILADELPHIA — A Pennsylvania federal judge on Nov. 12 said a whistleblower’s claims that Sanofi caused the submission of false claims through its use of advisory boards, speaker programs and educational...
To view the full article, register now.